Quality, Equity and Utility of Observational Studies during 10 Years of Implementing the Structured Operational Research and Training Initiative in 72 Countries
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. The SORT IT Program
2.3. Publication Characteristics Including Authorship and Collaborative Partnerships
2.4. Time to Publication, Access Type and Article Usage Metrics
2.5. Completeness of Reporting in Line with the STROBE Statement
2.6. Study Inclusion and Period
2.7. Data Sources, Collection and Statistical Analysis
2.8. Ethics
3. Results
3.1. SORT IT Courses and Publication Outputs
3.2. Publications, Authorship Characteristics and Collaborative Partnerships
3.3. Time to Publication, Article Access Type and Usage Metrics
3.4. Completeness of Reporting in the STROBE Checklist
4. Discussion
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Data Availability Statement
References
- Zachariah, R.; Harries, A.D.; Ishikawa, N.; Rieder, H.L.; Bissell, K.; Laserson, K.; Massaquoi, M.; Van Herp, M.; Reid, T. Operational research in low-income countries: What, why, and how? Lancet Infect. Dis. 2009, 9, 711–717. [Google Scholar] [CrossRef] [Green Version]
- WHO. World Health Organisation. The World Health Report 2013: Research for Universal Health Coverage. World Health Organization, Geneva. Available online: http://apps.who.int/iris/bitstream/10665/85761/2/9789240690837_eng.pdf (accessed on 13 March 2014).
- Rujumba, J.; Byamugisha, R. Publishing operational research from ‘real life’ programme data: A better form of accountability. Trop. Med. Int. Health 2012, 17, 133–134. [Google Scholar] [CrossRef] [Green Version]
- Walley, J.; Khan, M.A.; Shah, S.K.; Witter, S.; Wei, X. How to get research into practice: First get practice into research. Bull. World Health Organ. 2007, 85, 424. [Google Scholar] [CrossRef]
- von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gotzsche, P.C.; Vandenbroucke, J.P.; Initiative, S. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Bull. World Health Organ. 2007, 85, 867–872. [Google Scholar] [CrossRef] [PubMed]
- WHO. World Health Organisation. Research & Development Blueprint. Available online: https://www.who.int/teams/blueprint/covid-19 (accessed on 4 April 2020).
- Hales, S.; Lesher-Trevino, A.; Ford, N.; Maher, D.; Ramsay, A.; Tran, N. Reporting guidelines for implementation and operational research. Bull. World Health Organ. 2016, 94, 58–64. [Google Scholar] [CrossRef]
- Tripathy, J.P.; Kumar, A.M.; Guillerm, N.; Berger, S.D.; Bissell, K.; Reid, A.; Zachariah, R.; Ramsay, A.; Harries, A.D. Does the Structured Operational Research and Training Initiative (SORT IT) continue to influence health policy and/or practice? Glob. Health Action 2018, 11, 1500762. [Google Scholar] [CrossRef] [Green Version]
- Egger, M.; Schneider, M.; Smith, G.D. Spurious precision? Meta-analysis of observational studies. BMJ 1998, 316, 140–144. [Google Scholar] [CrossRef] [PubMed]
- Pocock, S.J.; Collier, T.J.; Dandreo, K.J.; de Stavola, B.L.; Goldman, M.B.; Kalish, L.A.; Kasten, L.E.; McCormack, V.A. Issues in the reporting of epidemiological studies: A survey of recent practice. BMJ 2004, 329, 883. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tooth, L.; Ware, R.; Bain, C.; Purdie, D.M.; Dobson, A. Quality of reporting of observational longitudinal research. Am. J. Epidemiol. 2005, 161, 280–288. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ramsay, A.; Harries, A.D.; Zachariah, R.; Bissell, K.; Hinderaker, S.G.; Edginton, M.; Enarson, D.A.; Satyanarayana, S.; Kumar, A.M.V.; Hoa, N.B.; et al. The Structured Operational Research and Training Initiative for public health programmes. Public Health Action 2014, 4, 79–84. [Google Scholar] [CrossRef] [Green Version]
- Harries, A.D.; Khogali, M.; Kumar, A.M.V.; Satyanarayana, S.; Takarinda, K.C.; Karpati, A.; Olliaro, P.; Zachariah, R. Building the capacity of public health programmes to become data rich, information rich and action rich. Public Health Action 2018, 8, 34–36. [Google Scholar] [CrossRef] [PubMed]
- TDR. UNICEF, UNDP, World Bank, World Health Organisation, Special Programme for Research and Training in Tropical Diseases (TDR). SORT IT Coverage and Outputs. Available online: https://www.who.int/tdr/capacity/strengthening/sort/en/ (accessed on 4 April 2020).
- Zachariah, R.; Guillerm, N.; Berger, S.; Kumar, A.M.; Satyanarayana, S.; Bissell, K.; Edginton, M.; Hinderaker, S.G.; Tayler-Smith, K.; Van den Bergh, R.; et al. Research to policy and practice change: Is capacity building in operational research delivering the goods? Trop. Med. Int. Health 2014, 19, 1068–1075. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kumar, A.M.V.; Shewade, H.D.; Tripathy, J.P.; Guillerm, N.; Tayler-Smith, K.; Dar Berger, S.; Bissell, K.; Reid, A.J.; Zachariah, R.; Harries, A.D. Does research through Structured Operational Research and Training (SORT IT) courses impact policy and practice? Public Health Action 2016, 6, 44–49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pinnock, H.; Barwick, M.; Carpenter, C.R.; Eldridge, S.; Grandes, G.; Griffiths, C.J.; Rycroft-Malone, J.; Meissner, P.; Murray, E.; Patel, A.; et al. Standards for Reporting Implementation Studies (StaRI) Statement. BMJ 2017, 356, i6795. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zachariah, R.; Kumar, A.M.V.; Reid, A.J.; Van den Bergh, R.; Isaakidis, P.; Draguez, B.; Delaunois, P.; Nagaraja, S.B.; Ramsay, A.; Reeder, J.C.; et al. Open access for operational research publications from low and middle-income countries: Who pays? Public Health Action 2014, 4, 141–144. [Google Scholar] [CrossRef] [Green Version]
- Hendriksma, M.; Joosten, M.H.; Peters, J.P.; Grolman, W.; Stegeman, I. Evaluation of the Quality of Reporting of Observational Studies in Otorhinolaryngology-Based on the STROBE Statement. PLoS ONE 2017, 12, e0169316. [Google Scholar] [CrossRef] [PubMed]
- Langan, S.; Schmitt, J.; Coenraads, P.J.; Svensson, A.; von Elm, E.; Williams, H.; European Dermato-Epidemiology, N. The reporting of observational research studies in dermatology journals: A literature-based study. Arch. Derm. 2010, 146, 534–541. [Google Scholar] [CrossRef] [Green Version]
- Aghazadeh-Attari, J.; Mobaraki, K.; Ahmadzadeh, J.; Mansorian, B.; Mohebbi, I. Quality of observational studies in prestigious journals of occupational medicine and health based on Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: A cross-sectional study. BMC Res. Notes 2018, 11, 266. [Google Scholar] [CrossRef] [Green Version]
- Huynh, N.; Baumann, A.; Loeb, M. Reporting quality of the 2014 Ebola outbreak in Africa: A systematic analysis. PLoS ONE 2019, 14, e0218170. [Google Scholar] [CrossRef]
- Edginton, M.; Enarson, D.; Zachariah, R.; Reid, T.; Satyanarayana, S.; Bissell, K.; Hinderaker, S.G.; Harries, T. Why ethics is indispensable for good-quality operational research. Public Health Action 2012, 2, 21–22. [Google Scholar] [CrossRef] [Green Version]
- Limaye, D.; Shankmanar, P.R.; Limaye, V.; Sydymanov, A.; Otzipka, C.; Zilesenis, P.; Fortwengel, G. Development of a quantitative scoring method for develpoment of a quantitative scoring method for STROBE chechlist. Acta Pol. Pharm. Ñ Drug Res. 2018, 75, 1095–1106. [Google Scholar]
- Poorolajal, J.; Cheraghi, Z.; Irani, A.D.; Rezaeian, S. Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement. Epidemiol. Health 2011, 33, e2011005. [Google Scholar] [CrossRef] [PubMed]
- Harries, A.D.; Marais, B.; Kool, B.; Ram, S.; Kumar, A.M.; Gounder, S.; Viney, K.; Brostrom, R.; Roseveare, C.; Bissell, K.; et al. Mentorship for operational research capacity building: Hands-on or hands-off? Public Health Action 2014, 4, S56–S58. [Google Scholar] [CrossRef] [Green Version]
- Iyer, A.R. Authorship trends in The Lancet Global Health. Lancet Glob. Health 2018, 6, e142. [Google Scholar] [CrossRef] [Green Version]
- Chaccour, J. Authorship trends in The Lancet Global Health: Only the tip of the iceberg? Lancet Glob. Health 2018, 6, e497. [Google Scholar] [CrossRef]
- Hedt-Gauthier, B.; Airhihenbuwa, C.O.; Bawah, A.A.; Burke, K.S.; Cherian, T.; Connelly, M.T.; Hibberd, P.L.; Ivers, L.C.; Jerome, J.G.; Kateera, F.; et al. Academic promotion policies and equity in global health collaborations. Lancet 2018, 392, 1607–1609. [Google Scholar] [CrossRef]
Characteristics of Published Papers | N | (%) |
---|---|---|
Total Publications | 392 | |
Number of Journals | 50 | |
Journal Impact Factor (Range) | 0–19 | |
LMIC Author | ||
First author | 370 | (94) |
Corresponding author | 367 | (94) |
Last author | 214 | (55) |
Gender Equity | ||
Female first author | 173 | (44) |
Affiliation of the First Author | ||
Disease control programs/Ministries of Health | 180 | (46) |
International or national NGOs | 133 | (33) |
Academic institutions | 63 | (16) |
WHO | 12 | (3) |
Donors | 4 | (1) |
Institutions | ||
Mean number from HICs (range) | 2.2 | (0–8) |
Mean number from LMICs (range) | 3.6 | (0–9) |
HIC-LMIC partnerships (n−31) 1 | 27 | (87) 1 |
LMIC-LMIC partnerships (n−361) 2 | 325 | (90) 2 |
Sex-Disaggregated Analysis | ||
Included in background and/or analysis | 204 | (52) |
Journal Access Type | ||
Immediate open access | 349 | (89) |
Delayed open access | 13 | (3) |
Subscription-based | 30 | (8) |
Article Views | ||
Papers with article view metrics | 153 | (39) |
Total views | 271428 | |
Article Downloads | ||
Papers with article download metrics | 95 | (24) |
Total downloads | 9127 | |
Article Citations | ||
Papers with article citation metrics | 153 | (39) |
Total citations | 998 |
Completeness of Reporting | N | (%) |
---|---|---|
Total Publications | 392 | |
STROBE Scores a | ||
>85% (Excellent) | 346 | (88.3) |
76–85% (Good) | 41 | (10.4) |
65–75% (Fair) | 5 | (1.3) |
<65% (Unsatisfactory) | 0 | (0) |
Item | Recommendation | Reported n (%) | Not Reported n (%) | Not Applicable n (%) |
---|---|---|---|---|
1a | (a) Indicate the study’s design with a commonly used term in the title or the abstract | 264 (67.3) | 128 (32.7) | 0 |
1b | (b) Provide in the abstract an informative and balanced summary of what was done and what was found | 390 (99.5) | 2 (0.5) | 0 |
2 | Explain the scientific background and rationale for the investigation being reported | 392 (100) | 0 | 0 |
3 | State specific objectives, including any pre-specified hypotheses | 391 (99.7) | 1 (0.3) | 0 |
4 | Present key elements of study design early in the paper | 392 (100) | 0 | 0 |
5a–g | Describe: setting, locations, relevant dates, periods of recruitment, exposure, follow-up, data | 392 (100) | 0 | 0 |
6a | (a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of participants. If applicable, describe methods of follow-up | 179 (100) | 0 | 0 |
6b | Case-control study—Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls | 6 (100) | 0 | 0 |
6c | Cross-sectional study—Give the eligibility criteria, and the sources and methods of selection of participants if applicable | 206 (99.5) | 1 (0.5) | 0 |
6d | (b) Cohort study—For matched studies, give matching criteria and number of exposed and unexposed | 0 | 0 | 179 (100) 1 |
7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | 388 (99.0) | 4 (1.0) | 0 |
8 | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | 390 (99.5) | 2 (0.5) | 0 |
9 | Describe any efforts to address potential sources of bias | 345 (88.0) | 47 (12.0) | 0 |
10 | Explain how the study size was determined | 391 (99.7) | 1 (0.3) | 0 |
11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | 387 (98.7) | 0 | 5 (1.3) |
12a | (a) Describe all statistical methods, and if applicable, those used to control for confounding | 304 (77.6) | 4 (1.0) | 84 (21.4) |
12b | (b) If applicable, describe any methods used to examine subgroups and interactions | 204 (52.0) | 13 (3.3) | 175 (44.7) |
12c | (c) If applicable, explain how missing data were addressed. | 136 (34.7) | 69 (17.6) | 187 (47.7) |
12d | (d) Cohort study—If applicable, explain how loss to follow-up was addressed | 51 (28.5) | 59 (33.0) | 69 (38.5) |
12e | Case-control study—If applicable, explain how matching of cases and controls was addressed | 4 (66.7) | 2 (33.3) | 0 |
12f | Cross-sectional study—If applicable, describe analytical methods taking account of sampling strategy | 29 (14.0) | 6 (2.9) | 172 (83.1) |
12g | (e) If applicable, describe any sensitivity analyses | 10 (2.6) | 1 (0.3) | 381 (97.1) |
13a | (a) Report numbers of individuals at each stage of study—e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed | 354 (90.3) | 0 | 38 (9.7) |
13b | (b) If applicable, give reasons for non-participation at each stage | 42 (10.7) | 6 (1.5) | 344 (87.8) |
13c | (c) If applicable, consider use of a flow diagram | 105 (26.8) | 8 (2.0) | 279 (71.2) |
14a | (a) Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders | 346 (88.3) | 1 (0.3) | 45 (11.4) |
14b | (b) If applicable, Indicate number of participants with missing data for each variable of interest | 225 (57.4) | 25 (6.5) | 142 (36.1) |
14c | (c) Cohort study—If applicable, summarize follow-up time (e.g., average and total amount) | 92 (51.4) | 20 (11.2) | 67 (37.4) |
15a | Cohort study—Report numbers of outcome events or summary measures over time | 179 (100) 1 | 0 | 0 |
15b | Case-control study—Report numbers in each exposure category, or summary measures of exposure | 6 (100) 1 | 0 | 0 |
15c | Cross-sectional study—Report numbers of outcome events or summary measures | 196 (95) 1 | 0 | 11(5) |
16a | (a) If applicable, give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval). Make clear which confounders were adjusted for and why they were included | 286 (73.0) | 2 (0.5) | 104 (26.5) |
16b | (b) If applicable, report category boundaries when continuous variables were categorized | 176 (45.0) | 1 (0.3) | 215 (54.7) |
16c | (c) If applicable and relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | 25 (6.4) | 5 (1.2) | 362 (92.4) |
17 | Report other analyses done—e.g., analyses of subgroups and interactions, and sensitivity analyses | 75 (19.1) | 7 (1.8) | 310 (79.1) |
18 | Summarize key results with reference to study objectives | 392 (100) | 0 | 0 |
19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | 388 (99.0) | 4 (1.0) | 0 |
20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | 392 (100) | 0 | 0 |
21 | Discuss the generalizability (external validity) of the study results | 355 (90.5) | 37 (9.5) | 0 |
22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | 390 (99.5) | 2 (0.5) | 0 |
23 | Local relevance of the research question indicated/mentioned in the paper | 392 (100) | 0 | 0 |
24 | Ethics statement included | 391 (99.8) | 1 (0.3) | 0 |
Total Percentage | 74.0% | 3.4% | 23% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. World Health Organization; Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricteduse, distribution, and reproduction in any medium, provided the original work is properlycited. In any reproduction of this article there should not be any suggestion that WHO orthis article endorse any specific organization or products. The use of the WHO logo is not permitted.
Share and Cite
Zachariah, R.; Rust, S.; Thekkur, P.; Khogali, M.; Kumar, A.M.; Davtyan, K.; Diro, E.; Satyanarayana, S.; Denisiuk, O.; Griensven, J.v.; et al. Quality, Equity and Utility of Observational Studies during 10 Years of Implementing the Structured Operational Research and Training Initiative in 72 Countries. Trop. Med. Infect. Dis. 2020, 5, 167. https://doi.org/10.3390/tropicalmed5040167
Zachariah R, Rust S, Thekkur P, Khogali M, Kumar AM, Davtyan K, Diro E, Satyanarayana S, Denisiuk O, Griensven Jv, et al. Quality, Equity and Utility of Observational Studies during 10 Years of Implementing the Structured Operational Research and Training Initiative in 72 Countries. Tropical Medicine and Infectious Disease. 2020; 5(4):167. https://doi.org/10.3390/tropicalmed5040167
Chicago/Turabian StyleZachariah, Rony, Stefanie Rust, Pruthu Thekkur, Mohammed Khogali, Ajay MV Kumar, Karapet Davtyan, Ermias Diro, Srinath Satyanarayana, Olga Denisiuk, Johan van Griensven, and et al. 2020. "Quality, Equity and Utility of Observational Studies during 10 Years of Implementing the Structured Operational Research and Training Initiative in 72 Countries" Tropical Medicine and Infectious Disease 5, no. 4: 167. https://doi.org/10.3390/tropicalmed5040167
APA StyleZachariah, R., Rust, S., Thekkur, P., Khogali, M., Kumar, A. M., Davtyan, K., Diro, E., Satyanarayana, S., Denisiuk, O., Griensven, J. v., Hermans, V., Berger, S. D., Saw, S., Reid, A., Aseffa, A., Harries, A. D., & Reeder, J. C. (2020). Quality, Equity and Utility of Observational Studies during 10 Years of Implementing the Structured Operational Research and Training Initiative in 72 Countries. Tropical Medicine and Infectious Disease, 5(4), 167. https://doi.org/10.3390/tropicalmed5040167